Renske van den Bijgaart and Gosse Adema, theme Cancer development and immune defence received a grant from Villa Joep, entitled “Bifunctional anti-GD2 antibodies co-targeting innate immune checkpoints to improve immunotherapy of Neuroblastoma”.
In this grant the, ROI research team will develop novel bifunctional monoclonal antibody formats that target the GD2 tumor-associated antigen on Neuroblastoma (NBL) and locally activate the immune system.
Renske van den Bijgaart and Gosse Adema both are from the Radiotherapy & OncoImmunology (ROI) laboratory (Department of Radiation Oncology) and in collaboration with the Prinses Maxima Center (Peter Hoogerbrugge) they received this Villa Joep grant of 410K Euro.
Want to know more about these subjects? Click on the buttons below for more news.